• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

无强化脑转移瘤。

Nonenhancing brain metastases.

机构信息

Memorial Sloan-Kettering Cancer Center, New York, NY 10065, USA.

出版信息

J Neuroimaging. 2011 Apr;21(2):184-7. doi: 10.1111/j.1552-6569.2009.00389.x.

DOI:10.1111/j.1552-6569.2009.00389.x
PMID:19490401
Abstract

The hallmark radiological finding in metastatic brain disease is multiple enhancing lesions. We report a case of metastatic lung cancer to the brain with a lack of contrast enhancement. We believe that this unusual finding is due to inadvertent "treatment" of the metastases with the antiangiogenic agent bevacizumab (Avastin).

摘要

转移性脑疾病的标志性放射学发现是多发强化病变。我们报告了一例脑转移肺癌病例,该病例缺乏对比增强。我们认为这种不寻常的发现是由于抗血管生成药物贝伐珠单抗(阿瓦斯汀)无意中“治疗”了转移灶。

相似文献

1
Nonenhancing brain metastases.无强化脑转移瘤。
J Neuroimaging. 2011 Apr;21(2):184-7. doi: 10.1111/j.1552-6569.2009.00389.x.
2
PD-1 inhibitors plus chemotherapy in EGFR/ALK-positive NSCLC patients with brain metastases and disease progression after EGFR/ALK-TKIs therapy.PD-1 抑制剂联合化疗治疗 EGFR/ALK 阳性 NSCLC 患者脑转移和 EGFR/ALK-TKIs 治疗后疾病进展。
J Cancer Res Clin Oncol. 2022 Dec;148(12):3557-3566. doi: 10.1007/s00432-022-04177-w. Epub 2022 Jul 20.
3
Longitudinal MRI evaluation of the efficacy of non-enhanced lung cancer brain metastases.非增强型肺癌脑转移疗效的纵向磁共振成像评估
Sci Rep. 2025 Jan 27;15(1):3318. doi: 10.1038/s41598-025-87422-9.
4
Bevacizumab biosimilar candidate TAB008 compared to Avastin in patients with locally advanced, metastatic EGFR wild-type non-squamous non-small cell lung cancer: a randomized, double-blind, multicenter study.贝伐单抗生物类似药候选药物TAB008与阿瓦斯汀治疗局部晚期、转移性表皮生长因子受体野生型非鳞状非小细胞肺癌患者的比较:一项随机、双盲、多中心研究。
J Cancer Res Clin Oncol. 2023 Aug;149(9):5907-5914. doi: 10.1007/s00432-022-04563-4. Epub 2023 Jan 3.
5
Cost-effectiveness analysis of first-line gifitinib plus pemetrexed-platinum-based chemotherapy versus gifitinib monotherapy in EGFR-mutated NSCLC patients with brain metastases.吉非替尼联合培美曲塞铂类一线化疗与吉非替尼单药治疗表皮生长因子受体(EGFR)突变的非小细胞肺癌脑转移患者的成本效益分析
BMC Health Serv Res. 2025 Aug 27;25(1):1136. doi: 10.1186/s12913-025-13322-3.
6
Matching-Adjusted Indirect Comparison of Sotorasib Versus Adagrasib in Previously Treated Advanced/Metastatic Non-Small Cell Lung Cancer Harboring KRAS G12C Mutation.在既往接受过治疗的携带KRAS G12C突变的晚期/转移性非小细胞肺癌中,索托拉西布与阿达格拉西布的匹配调整间接比较
Adv Ther. 2025 Jun 21. doi: 10.1007/s12325-025-03259-8.
7
Magnetic resonance imaging characteristics of small cell and non-small cell lung cancer brain metastases: a retrospective study.小细胞肺癌和非小细胞肺癌脑转移瘤的磁共振成像特征:一项回顾性研究。
J Med Life. 2025 Jun;18(6):563-574. doi: 10.25122/jml-2024-0411.
8
Chemotherapy with cetuximab versus chemotherapy alone for chemotherapy-naive advanced non-small cell lung cancer.西妥昔单抗联合化疗与单纯化疗用于初治晚期非小细胞肺癌的疗效比较
Cochrane Database Syst Rev. 2014 Nov 17;2014(11):CD009948. doi: 10.1002/14651858.CD009948.pub2.
9
Comprehensive Analysis of Lung Cancer Metastasis: Sites, Rates, Survival, and Risk Factors-A Systematic Review and Meta-Analysis.肺癌转移的综合分析:部位、发生率、生存率及危险因素——一项系统评价与荟萃分析
Clin Respir J. 2025 Jul;19(7):e70107. doi: 10.1111/crj.70107.
10
Surgery for limited-stage small-cell lung cancer.局限期小细胞肺癌的手术治疗
Cochrane Database Syst Rev. 2017 Apr 21;4(4):CD011917. doi: 10.1002/14651858.CD011917.pub2.

引用本文的文献

1
A non-enhancing, T2 fluid-attenuated inversion recovery hyperintense, diffusion-restricting brainstem lesion in an EGFR tyrosine kinase inhibitor-treated non-small-cell lung cancer patient.一名表皮生长因子受体酪氨酸激酶抑制剂治疗的非小细胞肺癌患者,脑部存在一处非增强、T2 液体衰减反转恢复高信号、弥散受限的脑干病变。
Biomark Med. 2024;18(9):431-439. doi: 10.1080/17520363.2024.2342231. Epub 2024 May 24.
2
A rare non-gadolinium enhancing sarcoma brain metastasis with microenvironment dominated by tumor-associated macrophages.脑转移肉瘤伴肿瘤相关巨噬细胞为主的微环境,罕见非钆增强表现。
Acta Neuropathol Commun. 2024 Jan 22;12(1):15. doi: 10.1186/s40478-023-01713-8.
3
Case Report: Atypical Solitary Brain Metastasis: The Role of MR Spectroscopy In Differential Diagnosis.
病例报告:非典型孤立性脑转移瘤:磁共振波谱在鉴别诊断中的作用
Front Oncol. 2022 Jul 22;12:866622. doi: 10.3389/fonc.2022.866622. eCollection 2022.
4
FLAIR hyperintensity along the brainstem surface in leptomeningeal metastases: a case series and literature review.脑表面 FLAIR 高信号在软脑膜转移瘤中的表现:病例系列和文献复习。
Cancer Imaging. 2020 Nov 23;20(1):84. doi: 10.1186/s40644-020-00361-8.
5
Cerebral Metastases of Lung Cancer Mimicking Multiple Ischaemic Lesions - A Case Report and Review of Literature.酷似多发缺血性病变的肺癌脑转移——1例病例报告及文献复习
Pol J Radiol. 2017 Sep 15;82:530-535. doi: 10.12659/PJR.902213. eCollection 2017.
6
Nonenhancing Leptomeningeal Metastases: Imaging Characteristics and Potential Causative Factors.非强化性软脑膜转移瘤:影像学特征及潜在病因
Neurohospitalist. 2016 Jan;6(1):24-8. doi: 10.1177/1941874415591702.
7
Update and developments in the treatment of glioblastoma multiforme - focus on bevacizumab.多形性胶质母细胞瘤治疗的最新进展与动态——聚焦贝伐单抗
Pharmgenomics Pers Med. 2010;3:79-85. doi: 10.2147/pgpm.s7940. Epub 2010 Jun 9.